Two new Ebola vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo (DRC) as the country continues to battle a deadly outbreak caused by the Bundibugyo species of the virus.
Source: UN News: Health · 05 Nov 2026
Summary prepared automatically from the source headline and excerpt. Read the original for the full story.
Comments (0)
No comments yet. Be the first to share a thought.
Leave a comment